Contact information
Research groups
Angela McBride
Clinical Research Fellow in Dengue Trials
Working closely with the dengue team at OUCRU Vietnam, Angela's work involves the design and set-up of clinical trials for dengue (including anti-viral agents and host-directed therapeutics targeting excessive inflammation and endothelial permeability). Angela is also involved in a collaborative effort to develop a Core Outcome Set for dengue trials.
Recent publications
Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)
Journal article
Yacoub S. et al, (2026), The Lancet Infectious Diseases, 26, e231 - e244
Dengue therapeutics consortium 2025: a global collaboration in action
Journal article
McBride A. et al, (2026), BMJ Public Health, 4, e004043 - e004043
Persistent Subclinical Inflammation and Long-term Functional and Cognitive Outcomes After Dengue Shock and Septic Shock in Vietnam
Journal article
McBride A. et al, (2025), Open Forum Infectious Diseases, 12
The cost of dengue shock and septic shock in Vietnam: a patient-centred economic analysis
Journal article
McBride A. et al, (2025), International Health
Safety and tolerability of metformin in overweight and obese patients with dengue: An open-label clinical trial (MeDO)
Journal article
Minh Nguyen N. et al, (2025), PLOS Neglected Tropical Diseases, 19, e0013281 - e0013281